article thumbnail

UK Agency targets blood thinners in personalised medicine pursuit

Pharmaceutical Technology

The MHRA kicks off phase two of the Yellow Card biobank to explore the genetic link to side effects of direct oral anticoagulants.

article thumbnail

UK agency pilots biobank to study links between genetics and drug side effects

Pharmaceutical Technology

The Medicines and Healthcare products Regulatory Agency (MHRA) aims to launch a pilot genetic biobank that will gather patient data to associate drug-related adverse events to their genetic makeup. The Yellow Card biobank will launch as a joint venture with the UK-government funded entity Genomics England on June 1.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Biobanks VS Biorepositories: The Difference

Cloudbyz

The short answer is that all Biobanks are Biorepositories, but not all Biorepositories are Biobanks. Realistically speaking, the terms “Biobank” and “Biorepository” are used pretty interchangeably. The differences we can point out when someone asks: What is the difference between Biobanks and Biorepositories?

article thumbnail

Screening UK Biobank blood samples identifies thousands of undiagnosed cases of type 2 diabetes

Scienmag

A study of approximately 200,000 blood samples from the UK Biobank has identified more than 2,000 undiagnosed cases of type 2 diabetes.

article thumbnail

San Diego zoo global biobanking advances wildlife conservation and human medicine worldwide

Scienmag

In a study that has unprecedented implications to advance both medicine and biodiversity conservation, researchers have sequenced 131 new placental mammal genomes, bringing the worldwide total to more than 250 In a study that has unprecedented implications to advance both medicine and biodiversity conservation, researchers have sequenced 131 new placental (..)

article thumbnail

Associations of Daily Steps With Cancer, Cardiovascular Disease, and Mortality

JAMA Internal Medicine

This population-based prospective cohort study using UK Biobank data for 78 500 individuals with 7 years of follow-up examines associations of daily step counts and intensity with all-cause mortality and cancer and cardiovascular disease-related morbidity and mortality.

article thumbnail

Coffee Consumption and Incident Tachyarrhythmias

JAMA Internal Medicine

This cohort study assesses the association between consumption of common caffeinated products and the risk of arrhythmias using data from the UK Biobank.